Safety and Immunogenicity of Additional SARS-CoV-2 Vaccinations in a Patient With Myasthenia Gravis on Mycophenolate: A Case Report

J Clin Neuromuscul Dis. 2022 Dec 1;24(2):113-114. doi: 10.1097/CND.0000000000000405.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Myasthenia Gravis* / complications
  • Myasthenia Gravis* / drug therapy
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Immunosuppressive Agents